Scientists form new Seattle biotech, backed by $12M. Fate Therapeutics

November 30, 2007

A group of scientists who specialize in stem cell biology have formed a new biotech company backed by $12 million in original venture capital.

Fate Therapeutics will be based in Seattle and consists of leading scientists including Randall Moon of the University of Washington, who's director of the Institute for Stem Cell and Regenerative Medicine. Other scientists come from Stanford University, Harvard University and Scripps Research Institute.

Full Story: http://www.bizjournals.com/seattle/stories/2007/11/26/daily23.html?ana=from_rss